{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T11:09:09Z","timestamp":1778411349022,"version":"3.51.4"},"reference-count":67,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["MDM Policy &amp; Practice"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    <jats:bold>Introduction.<\/jats:bold>\n                    The recent expansion of treatment options for older adults with blood cancers has increased the necessity for understanding patient preferences and values to inform treatment decision making. Currently, no values elicitation measures have been validated for clinical use in this population. Values-HM (Values elicitation measure for Hematologic Malignancies) is a novel values elicitation measure based on best\u2013worst scaling. It was developed specifically for older adults with blood cancers involving multiple stakeholders including patients, caregivers, and clinicians.\n                    <jats:bold>Objective.<\/jats:bold>\n                    The objective of this study was to test the preliminary validity, reliability, and acceptability of this measure for clinical use based on US Food and Drug Administration and International Society for Pharmacoeconomics and Outcomes Research guidance.\n                    <jats:bold>Results.<\/jats:bold>\n                    Twenty-nine adults aged\u2009\u226560\u2009y with newly diagnosed lymphoma, leukemia, myelodysplastic syndrome, and multiple myeloma were enrolled. Most patients were White (97%). Most patients (88%) felt that the measure was relevant to them, showed their real preferences (73%), and was acceptable to clarify their preferences (68%). The measure demonstrated discriminant validity of importance scores and convergent validity for most patients (77%) with a ranking exercise of the treatment values. Cognitive interviews with 10 participants suggested question comprehension, outcome understanding, and appropriate judgment. Data from 18 participants who completed the measure more than once provide some evidence for the reliability of the measure to capture repeated values over time.\n                    <jats:bold>Conclusions.<\/jats:bold>\n                    These initial data suggest that Values-HM may be acceptable to patients and valid and reliable to capture patient values. Additional data are needed to confirm these findings in a larger and more diverse sample. This trial was registered at\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\">www.clinicaltrials.gov<\/jats:ext-link>\n                    as #NCT05061095.\n                  <\/jats:p>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>Values-HM is a novel values elicitation measure designed based on best\u2013worst scaling for adults with blood cancers.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Values-HM appears to be acceptable to patients and may be valid and reliable to capture patient values in clinical care.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1177\/23814683261440935","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:50:54Z","timestamp":1778205054000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Developing a Novel Values Elicitation Measure for Clinical Use in Older Adults with Hematologic Malignancies: Values-HM"],"prefix":"10.1177","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9310-5773","authenticated-orcid":false,"given":"Daniel R.","family":"Richardson","sequence":"first","affiliation":[{"name":"UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA"},{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison M.","family":"Deal","sequence":"additional","affiliation":[{"name":"UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl J.","family":"Mhina","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"},{"name":"Duke University Department of Population Health Sciences, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Washko","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9478-6005","authenticated-orcid":false,"given":"Amy C.","family":"Cole","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-1330","authenticated-orcid":false,"given":"Norah L.","family":"Crossnohere","sequence":"additional","affiliation":[{"name":"The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kah Poh","family":"Loh","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, James P Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-9318","authenticated-orcid":false,"given":"Ethan","family":"Basch","sequence":"additional","affiliation":[{"name":"UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA"},{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie B.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Wood","sequence":"additional","affiliation":[{"name":"UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA"},{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F. P.","family":"Bridges","sequence":"additional","affiliation":[{"name":"The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"LeBlanc","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia V.","family":"Bennett","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"SEER. SEER cancer stat facts. Available from:http:\/\/seer.cancer.gov\/statfacts\/index.html. [Accessed 27 June 2022]."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100670"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010087"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-1277"},{"issue":"10","key":"e_1_3_2_6_2","article-title":"Treatment preferences among patients with diffuse large B-cell lymphoma: a survey across western Europe and the United States","volume":"28","author":"Johnson P","year":"2022","unstructured":"Johnson P, Quek R, Bailey A, et al. Treatment preferences among patients with diffuse large B-cell lymphoma: a survey across western Europe and the United States. J Manag Care Spec Pharm. 2022;28(10):S34.","journal-title":"J Manag Care Spec Pharm"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.01.016"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051147"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178754"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00165"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-012-2077-6"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001920"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2011.12.014"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32961"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/pon.4309"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008812"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/pon.4414"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.192468"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1832662"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15566"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2015.11.006"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-010-0218-6"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2021.0490"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.17226\/18359"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.25.4672"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.10168"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X211037946"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.04.004"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.11.013"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2017.1389648"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.15818"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/0825859718810723"},{"key":"e_1_3_2_33_2","unstructured":"Bonamici S. H.R.34 114th Congress (2015-2016): 21st Century Cures Act. 2016. Available from: https:\/\/www.congress.gov\/bill\/114th-congress\/house-bill\/34. [Accessed 27 May 2020]."},{"key":"e_1_3_2_34_2","unstructured":"Wicker RF. S. 1597 114th Congress (2015-2016): Patient-Focused Impact Assessment Act of 2016. Available from: https:\/\/www.congress.gov\/bill\/114th-congress\/senate-bill\/1597. [Accessed 27 May 2020]."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1456414"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S151752"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/pon.5652"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-05654-3_14"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1109\/VAHC57815.2022.10108523"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcomm.2024.1347310"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2006.04.002"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-022-01167-1"},{"key":"e_1_3_2_43_2","unstructured":"US Department of Health and Human Services Food and Drug Administration. Patient preference information \u2013 voluntary submission review in premarket approval applications humanitarian device exemption applications and de novo requests and inclusion in decision summaries and device labeling: guidance for industry food and drug administration staff and other stakeholders. 2016. Available from: https:\/\/www.fda.gov\/downloads\/medicaldevices\/deviceregulationandguidance\/guidancedocuments\/ucm446680.pdf. [Accessed 18 March 2019]."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.06.014"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.06.013"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008041"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1937"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.12.007"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08397-3"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-018-0330-8"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.07.001"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.21037\/jhmhp-20-105"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-010-0319-7"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00603.x"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1037\/\/0033-2909.86.2.420"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-2644"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.245803"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.8687"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00933"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1988.tb02362.x"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35333"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5547"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16875"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.9265"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03507-y"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_200383"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02909-8"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2025.102187"}],"container-title":["MDM Policy &amp; Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23814683261440935","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23814683261440935","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23814683261440935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T10:46:14Z","timestamp":1778409974000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23814683261440935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1177\/23814683261440935"],"URL":"https:\/\/doi.org\/10.1177\/23814683261440935","relation":{},"ISSN":["2381-4683","2381-4683"],"issn-type":[{"value":"2381-4683","type":"print"},{"value":"2381-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"23814683261440935"}}